Publikation:

ADP‐ribosyltransferases, an update on function and nomenclature

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2022

Autor:innen

Lüscher, Bernhard
Ahel, Ivan
Altmeyer, Matthias
Ashworth, Alan
Bai, Peter
Chang, Paul
Cohen, Michael
Corda, Daniela
Dantzer, Françoise
et al.

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
DOI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

The FEBS Journal. Wiley. 2022, 289(23), pp. 7399-7410. ISSN 1742-464X. eISSN 1742-4658. Available under: doi: 10.1111/febs.16142

Zusammenfassung

ADP-ribosylation, a modification of proteins, nucleic acids and metabolites, confers broad functions, including roles in stress responses elicited for example by DNA damage and viral infection and is involved in intra- and extracellular signaling, chromatin and transcriptional regulation, protein biosynthesis and cell death. ADP-ribosylation is catalyzed by ADP-ribosyltransferases, which transfer ADP-ribose from NAD+ onto substrates. The modification, which occurs as mono- or poly-ADP-ribosylation, is reversible due to the action of different ADP-ribosylhydrolases. Importantly, inhibitors of ADP-ribosyltransferases are approved or are being developed for clinical use. Moreover, ADP-ribosylhydrolases are being assessed as therapeutic targets, foremost as anti-viral drugs and for oncological indications. Due to the development of novel reagents and major technological advances that allow the study of ADP-ribosylation in unprecedented detail, an increasing number of cellular processes and pathways are being identified that are regulated by ADP-ribosylation. In addition, characterization of biochemical and structural aspects of the ADP-ribosyltransferases and their catalytic activities have expanded our understanding of this protein family. This increased knowledge requires that a common nomenclature be used to describe the relevant enzymes. Therefore, in this viewpoint, we propose an updated and broadly supported nomenclature for mammalian ADP-ribosyltransferases that will facilitate future discussions when addressing the biochemistry and biology of ADP-ribosylation. This is combined with a brief description of the main functions of mammalian ADP-ribosyltransferases to illustrate the increasing diversity of mono- and poly-ADP-ribose mediated cellular processes.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

ADP-ribosylation, MARylation, PARP, PARylation, posttranslational modification

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Zugehörige Datensätze in KOPS

Zitieren

ISO 690LÜSCHER, Bernhard, Ivan AHEL, Matthias ALTMEYER, Alan ASHWORTH, Peter BAI, Paul CHANG, Michael COHEN, Daniela CORDA, Françoise DANTZER, Aswin MANGERICH, 2022. ADP‐ribosyltransferases, an update on function and nomenclature. In: The FEBS Journal. Wiley. 2022, 289(23), pp. 7399-7410. ISSN 1742-464X. eISSN 1742-4658. Available under: doi: 10.1111/febs.16142
BibTex
@article{Luscher2022ADPri-54458,
  year={2022},
  doi={10.1111/febs.16142},
  title={ADP‐ribosyltransferases, an update on function and nomenclature},
  number={23},
  volume={289},
  issn={1742-464X},
  journal={The FEBS Journal},
  pages={7399--7410},
  author={Lüscher, Bernhard and Ahel, Ivan and Altmeyer, Matthias and Ashworth, Alan and Bai, Peter and Chang, Paul and Cohen, Michael and Corda, Daniela and Dantzer, Françoise and Mangerich, Aswin}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/54458">
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-07-29T14:19:32Z</dc:date>
    <dc:contributor>Altmeyer, Matthias</dc:contributor>
    <dc:creator>Lüscher, Bernhard</dc:creator>
    <dc:language>eng</dc:language>
    <dc:creator>Dantzer, Françoise</dc:creator>
    <dc:contributor>Dantzer, Françoise</dc:contributor>
    <dc:contributor>Ashworth, Alan</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Altmeyer, Matthias</dc:creator>
    <dc:creator>Cohen, Michael</dc:creator>
    <dc:creator>Bai, Peter</dc:creator>
    <dc:creator>Corda, Daniela</dc:creator>
    <dcterms:abstract xml:lang="eng">ADP-ribosylation, a modification of proteins, nucleic acids and metabolites, confers broad functions, including roles in stress responses elicited for example by DNA damage and viral infection and is involved in intra- and extracellular signaling, chromatin and transcriptional regulation, protein biosynthesis and cell death. ADP-ribosylation is catalyzed by ADP-ribosyltransferases, which transfer ADP-ribose from NAD+ onto substrates. The modification, which occurs as mono- or poly-ADP-ribosylation, is reversible due to the action of different ADP-ribosylhydrolases. Importantly, inhibitors of ADP-ribosyltransferases are approved or are being developed for clinical use. Moreover, ADP-ribosylhydrolases are being assessed as therapeutic targets, foremost as anti-viral drugs and for oncological indications. Due to the development of novel reagents and major technological advances that allow the study of ADP-ribosylation in unprecedented detail, an increasing number of cellular processes and pathways are being identified that are regulated by ADP-ribosylation. In addition, characterization of biochemical and structural aspects of the ADP-ribosyltransferases and their catalytic activities have expanded our understanding of this protein family. This increased knowledge requires that a common nomenclature be used to describe the relevant enzymes. Therefore, in this viewpoint, we propose an updated and broadly supported nomenclature for mammalian ADP-ribosyltransferases that will facilitate future discussions when addressing the biochemistry and biology of ADP-ribosylation. This is combined with a brief description of the main functions of mammalian ADP-ribosyltransferases to illustrate the increasing diversity of mono- and poly-ADP-ribose mediated cellular processes.</dcterms:abstract>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:title>ADP‐ribosyltransferases, an update on function and nomenclature</dcterms:title>
    <dc:contributor>Chang, Paul</dc:contributor>
    <dc:contributor>Lüscher, Bernhard</dc:contributor>
    <dc:contributor>Mangerich, Aswin</dc:contributor>
    <dc:creator>Mangerich, Aswin</dc:creator>
    <dc:creator>Ashworth, Alan</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Bai, Peter</dc:contributor>
    <dc:contributor>Corda, Daniela</dc:contributor>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Chang, Paul</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/54458"/>
    <dcterms:issued>2022</dcterms:issued>
    <dc:creator>Ahel, Ivan</dc:creator>
    <dc:contributor>Ahel, Ivan</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2021-07-29T14:19:32Z</dcterms:available>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Cohen, Michael</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen